Insider Transactions in Q4 2023 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,700
+50.0%
|
$2,700
$1.01 P/Share
|
|
Dec 27
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+35.29%
|
$27,000
$9.86 P/Share
|
|
Dec 18
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Direct |
1,724
-100.0%
|
$101,716
$59.24 P/Share
|
|
Dec 18
2023
|
Orbimed Advisors LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,724
+50.0%
|
$65,512
$38.0 P/Share
|
|
Dec 18
2023
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Direct |
1,724
-100.0%
|
$101,716
$59.24 P/Share
|
|
Dec 18
2023
|
Mona Ashiya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,724
+50.0%
|
$65,512
$38.0 P/Share
|
|
Dec 14
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
433,400
-12.18%
|
$24,703,800
$57.14 P/Share
|
|
Dec 14
2023
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
433,400
-12.18%
|
$24,703,800
$57.14 P/Share
|
|
Dec 14
2023
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
20,549
-1.24%
|
$1,212,391
$59.01 P/Share
|
|
Dec 14
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,549
-1.24%
|
$1,212,391
$59.01 P/Share
|
|
Dec 14
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,825
-1.02%
|
$1,818,675
$59.01 P/Share
|
|
Dec 13
2023
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
3,548
-0.21%
|
$212,880
$60.25 P/Share
|
|
Dec 13
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,548
-0.21%
|
$212,880
$60.25 P/Share
|
|
Dec 13
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,323
-0.18%
|
$319,380
$60.25 P/Share
|
|
Dec 13
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
106,700
-4.76%
|
$6,188,600
$58.56 P/Share
|
|
Dec 13
2023
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
106,700
-4.76%
|
$6,188,600
$58.56 P/Share
|
|
Dec 12
2023
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
51,967
-0.86%
|
$3,221,954
$62.98 P/Share
|
|
Dec 12
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,967
-0.86%
|
$3,221,954
$62.98 P/Share
|
|
Dec 12
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
77,951
-0.71%
|
$4,832,962
$62.98 P/Share
|
|
Dec 12
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
27,300
-1.2%
|
$1,638,000
$60.16 P/Share
|
|
Dec 12
2023
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
27,300
-1.2%
|
$1,638,000
$60.16 P/Share
|
|
Dec 12
2023
|
Joanne Bryce Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-50.0%
|
$162,500
$65.22 P/Share
|
|
Dec 12
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+33.33%
|
$5,000
$2.65 P/Share
|
|
Dec 12
2023
|
William Richard White |
SELL
Open market or private sale
|
Direct |
33,511
-55.31%
|
$2,111,193
$63.63 P/Share
|
|
Dec 12
2023
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
33,511
+28.09%
|
$268,088
$8.67 P/Share
|
|
Dec 05
2023
|
Joanne Bryce Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,541
-19.94%
|
$142,296
$56.3 P/Share
|
|
Dec 05
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,281
+11.98%
|
$1,281
$1.01 P/Share
|
|
Nov 22
2023
|
Rahul Khara General Counsel |
SELL
Open market or private sale
|
Direct |
10,000
-50.5%
|
$510,000
$51.05 P/Share
|
|
Nov 22
2023
|
Rahul Khara General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$140,000
$14.69 P/Share
|
|
Nov 14
2023
|
Rahul Khara General Counsel |
SELL
Open market or private sale
|
Direct |
4,900
-91.97%
|
$245,000
$50.79 P/Share
|
|
Nov 14
2023
|
Rahul Khara General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,900
+50.0%
|
$68,600
$14.69 P/Share
|
|
Nov 03
2023
|
Rahul Khara General Counsel |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$5,000
$50.0 P/Share
|
|
Nov 03
2023
|
Rahul Khara General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$1,400
$14.69 P/Share
|